Consumer Spec - Pre Market Wrap
WEN Pre Squeeze, NKE CFO Comments | CCL Yield Trim, HTZ EBITDA Cut, KMX Residual Read, CELH PT Cut, BBWI ULTA Launch, DRI Thursday Preview, CAG S&P500 Removal, Evercore Bull Call
I think Crude -3% and trading heavy to the downside can be a positive driver for consumer names today, specifically names like CCL (overall good nrs yesterday), cruiselines and airlines. Some hint of that can be seen in the gappers list as both CCL and NCLH are in the top pre-market movers today.
In consumer world, there’s a few headlines this morning to note: WEN rips +22% on a WallStreetBets short squeeze setup against ~30% short interest — purely meme-tape mechanics, not fundamentals. NKE CFO change dominates the wire with Pfizer's David Denton replacing Matt Friend (should be a great guy); Evercore ISI flags earnings cut risk while Goldman calls it a fit, F4Q in-line ex a ~$500M tariff refund. Yesterday after the close CCL beat but trims FY26 yields to +3.2%, Jefferies + but stays $35 PT, HSBC is positive. CELH cut to $45 at BofA on Alani Nu deceleration. HTZ EBITDA cut drags KMX residual read. BBWI ULTA launch reads as channel shift, not demand. CAG S&P500 boot Monday.
MACRO & MARKETS
US STRATEGY (EVERCORE): BULL CALL INTACT; DOLLAR BREAKOUT, BANKS AND BUYOTECH LEAD
Rich Ross reiterates the bull call with credit composed, breadth expanding, and Banks, REITs and “Buyotech” breaking out while Value and Small Caps lead and the AI/Semis/Momentum theme remains intact into MU earnings Wednesday after the bell (”Step up to the MU”).
Ross flags Banks as “where the money is” with JPM and BAC joining MS, GS and C in breaking out alongside BKX (+11.5%), KRE (+12%) and SX7E (+12%), with credit spreads at multi-year tights; REITs remain “resplendent” +15.7% YTD with names like SPG, IRM and EQIX. The firm says “Buyotech” (+21%) should be bought along with large cap pharma, Managed Care and Distributors, notes Value (+15%) continues to dominate Growth (+1.7%) despite the AI boom, and argues “the hate has gone too far” on the Mag 7 which should be owned absolutely with all oversold and on support; adds “buy the dip in Semi-CAT equipment,” Memory, Machinery, Power and Semis, with Transports strong as Crude flounders and the economy doesn’t.
CONSUMER STREET RESEARCH
Upgrades
No upgrades in consumer sector today
Downgrades
No downgrades in consumer sector today
Initiations
No initiations in consumer sector toda
EARNINGS REPORTS
No earnings reports today
ANALYST RESEARCH & NEWS
WEN +20%: SUBJECT OF A POS. ARTICLE IN BARRON’S
Wendy’s surged 22% to $7.63 after WallStreetBets users called on retail investors to pile into the struggling fast-food chain, with the article noting the stock traded more actively than MU and INTC pre-market. The piece flags a setup for a potential short squeeze with short interest at just under 30% of public float, against a backdrop of shares down 47% over the past year as inflation-weary consumers pulled back on restaurant spending. The article highlights newly appointed CFO and Chief Strategy Officer Steve Cirulis (ex-Potbelly) joining CEO Robert Wright’s turnaround plan, though notes consensus is modeling sub-1% sales growth in 2026 with shares at ~11x forward earnings.
A few brokers commenting on NKE CFO change, my personal view is negative.
NKE: EVERCORE ISI FLAGS CFO TRANSITION CONCERNS
The firm views today’s CFO transition (David Denton joining August 17 from Pfizer to replace Matt Friend, who stays through September 4) as compounding concerns laid out in the firm’s recent downgrade. The analyst notes management said F4Q will be “generally in line” with prior guidance ex a tariff benefit and warns any change to prior F1H27 down-LSD revenue commentary will be heavily scrutinized; the firm also flags risk to the November Analyst Day timing given Denton’s mid-August start. The analyst believes a meaningful earnings cut ahead of the Analyst Day becomes more likely after today’s update and sees NKE’s mid-20s P/E as increasingly difficult to defend, with EV/Sales at 15-year lows not yet a buy signal absent clearer top-line stabilization.
NKE: NEEDHAM COMMENTS ON CFO TRANSITION
The firm notes the choice of outside hire David Denton (current Pfizer CFO, previously CFO of Lowe’s and CVS) to succeed Matt Friend in August is somewhat surprising given NKE’s mixed track record with outside hires for the CEO seat, though external CFO hires have historically worked (citing Don Blair’s 16-year tenure from PepsiCo). The analyst flags a likely “learning curve” for an executive joining the world’s largest athleticwear brand without industry experience, while the board appears focused on Denton’s public-company CFO experience, complex business management, and “operating rigor.” The firm notes F4Q26 results are expected to be mostly in line with prior guidance except for a one-time tariff-refund benefit, estimating NKE has paid ~$1B in incremental tariffs since Liberation Day and a ~50% refund could equate to a ~$500M tailwind to Q4 GP (~450bps to the quarter, ~100bps to FY), though timing may push some refunds into FY27.
NKE: GOLDMAN SACHS POSITIVE ON CFO HIRE
GS views the appointment of David Denton as Nike’s next CFO (effective August 17, replacing Matt Friend) as a strong fit, citing his public-company CFO experience at Pfizer, Lowe’s and CVS, and his prior Tapestry board service during the early Coach transformation as relevant branded consumer exposure. The analyst sees NKE’s reaffirmation of underlying F4Q results in line with prior guidance (ex a one-time tariff refund benefit) as a modest positive, but notes investor focus is more firmly centered on FY27 outlook commentary. The firm awaits clarification on the upcoming Fall Investor Day plans, with F4Q results due June 30.
CCL: JEFFERIES REITERATES BUY ON IMPROVING MARGINS AND STRONG FCF GENERATION, PT $35
The firm reiterates Buy on CCL despite the FY26 yield guidance trim, citing improving margins and >$9B in FCF generation across FY26 to FY27 supporting organic growth, de-leveraging, and capital returns. The analyst notes 2Q26 Adj. EBITDA of $1.48B beat by 6.9% and Adj. EPS of $0.41 beat by 20.6% vs the firm, while 3Q26 guidance came in soft (Adj. EBITDA $2.88B and EPS $1.35 vs Street $3.04B and $1.42) and FY26 net yields are now guided to +3.2% (from +4.1%). The firm trims estimates to reflect the yield guide-down partly offset by lower fuel and non-fuel costs, with new FY26/FY27 revenue of $27.6B/$28.8B and Adj. EBITDA of $7.17B/$7.90B; PT held at $35 on 9.0x EV/EBITDA, 15.0x P/E, and 10.5x P/FCF. The analyst adds that CCL has beat guidance on yields, NCCs ex fuel, EBITDA and EPS every quarter since 1Q25, suggesting today’s guide may again prove conservative.
CCL: HSBC MAINTAINS BUY BUT POSITIVE ON LEVERAGE IMPROVING AND EXPENSE CONTROLS, RAISES PT TO $31
The firm trims average FY26/27e Adj. EBITDA modestly (<1%) on a more measured near-term yield guide and lingering expense volatility, but raises TP to $31 from $30.50 on lower leverage and share count. The analyst notes 2Q CC net yield came in line at +2.2% YoY, with cost-saving initiatives (NCCx/ALBD flat YoY, 240bp below the firm) and lower-than-feared fuel (per ALBD 2.5% below the firm) driving Adj. EBITDA growth of +4.9% YoY (+6.5% vs firm), while customer deposits were +4.6% YoY and leverage improved to 3.1x from 4.4x in 2Q25. The firm cuts FY26/27e CC net yield by 50bp on softer near-term European demand and lower occupancy contribution, with NCC ex fuel per ALBD now +3.0% and fuel +5.0%. The analyst sees upside risk from multiple self-help levers across revenue management and onboard monetization and views the discounted valuation (12% below the 2-year pre-pandemic average on 2026e P/E) as already reflecting fuel and consumer concerns; TP based on 9.0x FY26e EV/EBITDA.
BBWI: JEFFERIES SAYS ULTA LAUNCH UPSIDE LIMITED BY OVERLAP
The firm maintains Hold with a $22 PT, viewing the July 12 BBWI launch at ULTA (curated assortment of ~55 SKUs across 600+ US doors, ~40% of the fleet, and ulta.com) as more of a channel shift than true demand creation. The analyst flags ~63% of BBWI stores already sit within one mile of a ULTA (the highest overlap across major retailers), creating cannibalization risk as BBWI continues to reposition toward an off-mall fleet (~75% target vs ~60% today). The firm acknowledges BBWI enters from category strength (22.4% share of the ~$2B US mass fragrance market and 21.5% of ~$6B home air care, including ~34% in candles) into ULTA’s strongest category (fragrance comping +high-teens% in Q1), but sees a natural ceiling from shelf competition with Sol de Janeiro, Snif, Saltair and Touchland. The analyst expects ULTA to be a smaller contributor than AMZN within the ~$50M FY26 new-channel revenue guide, with further scaling contingent on performance.
CELH: BOFA REITERATES BUY, CUTS PT TO $45 ON GROWTH DECELERATION
The firm cuts its PO to $45 from $55 on 15.5x (prior 18.4x) CY27 EV/EBITDA after retail sales trends for both Core Celsius and Alani Nu decelerated since 1Q26 results in early May. The analyst lowers 2Q26 sales to $849.7M from $874.8M and Adj. EBITDA to $202.4M from $208.1M (margin unchanged at ~24.0%), while 2H26 sales are reduced ~1.5%. Using latest NielsenIQ data, the firm now models Core Celsius 2Q26 sales down 4.3% YoY (prior flat) to $395.7M with QTD retail sales down 2.2% YoY and declines in 9 of the past 11 weeks, with management attributing weakness primarily to SKU rationalization;
HTZ -20%: CUTS Q2 EBITDA TO 50M-80M ON USED-CAR WEAKNESS, LAUNCHES 300M EXCHANGEABLES PLUS 100M SHARE-LENDING DEAL
HTZ cut Q2 Adjusted Corporate EBITDA guidance to 50M-80M (low end of prior range) on used-car market weakness, with May vehicle sale losses offsetting April gains and net DPU per month now expected at ~300. Offsetting positives: fleet, revenue, RPD, and rental days are tracking at or modestly above plan, demand is healthy, and YoY RPD growth in Q2-to-date has accelerated above the Q1 trend, framing the issue as disposition-side, not demand-side. Concurrent capital raise: a 300M Rule 144A offering of 2030 exchangeable senior first-lien secured PIK notes (45M greenshoe), proceeds earmarked for general corporate purposes including debt repayment, plus a 100M common-stock offering via a J.P. Morgan share-lending arrangement to facilitate note-investor hedging.
KMX: HERTZ USED-CAR COMMENTARY A SOFT NEGATIVE READ ON RESIDUALS
Off-coverage Hertz (HTZ) cut Q2 Adjusted Corporate EBITDA outlook to a range of 50M-80M, citing “unexpected weakness in the used car market.” The company flagged May 2026 vehicle sale losses offsetting April gains and now expects net DPU per month for Q2 of approximately 300. Soft negative read for KMX on used-car pricing and residual values, with secondary exposure across auto retail and aftermarket (AN, GPI, LAD, SAH, ABG, PAG). Mitigant: Hertz noted fleet size, revenue, RPD, and rental days are expected to meet or modestly exceed prior expectations, with YoY RPD growth accelerating versus Q1 trend, so the message is contained to the disposition/residual side rather than consumer rental demand.
DRI: GUGGENHEIM RAISES PT TO 235 FROM 230 AHEAD OF THURSDAY 4Q26 PRINT
Guggenheim raised the price target on DRI to 235 from 230 and reiterated Buy ahead of Thursday’s 4Q26 release. The firm says it models Olive Garden SSS ~100bps below consensus and LongHorn ~200bps above, with full-year 2027 guidance issued alongside earnings expected to bracket the Street. The analyst notes Middle East-related cost headwinds likely cap margin upside and limit positive earnings revisions, but views 17.8x C27 EPS as attractive for the growth profile. 2027 EPS estimate nudged to 11.30 from 11.25.
CAG will be removed from the S&P500 and added to the S&P smallcap 600 on Monday June 29th. Change follows Honeywell International spinning off Honeywell Aerospace in a transaction expected to be completed that day.
Thanks for reading! If you enjoyed Consumer Spec, we’d appreciate you sharing it.
EARNINGS CALENDAR
